News

26.10.2023

EMSP @ ECTRIMS 2023 – Key takeaways

Introduction EMSP at ECTRIMS 2023 Highlights of sessions attended by EMSP delegates Plenary session Epstein-Barr virus (EBV) and MS Transition…

Ground-breaking research with potential for MS treatments launched

22.09.2023

Targeting Epstein-Barr virus to treat and prevent MS Researchers launch pioneering EU funded research initiative to uncover role of Epstein-Barr…

EMSP’s reaction to the State of the European Union 2023: we need a Health Union which enhances opportunities for people with MS

13.09.2023

On 13 September, Ursula van der Leyen President of the European Commission, has delivered her annual State of the European…

07.09.2023

EMSP welcomes new Communications and Membership Coordinator

In July 2023, we said good bye to Máté Tagaj László, Senior Communications and Membership Coordinator, who worked with us…

Impact of Multiple Sclerosis Symptoms (IMSS) – Where are we now and what can you do?

24.07.2023

EMSP and 25 member organisations have launched their pan-European survey on the Impact of Multiple Sclerosis Symptoms (IMSS) in May…

Equipped for Impact: MS CAB Members Successfully Completed Training Program

29.06.2023

We are thrilled to share some exciting news from the Multiple Sclerosis Community Advisory Board (MSCAB) facilitated by Rob Camp…

29.06.2023

EMSP YPN at EYE 2023

On the exciting days of June 9th and 10th of 2023, the Young People’s Network of EMSP embarked on an…

What did the European MS Community do during World MS Day 2023?

30.05.2023

One month ago the global MS community joined forces on World MS Day (30 May) sharing stories, raising awareness and creating…

Impact of Multiple Sclerosis Symptoms (IMSS) Survey Now Live!

10.05.2023

We are pleased to announce that the Impact of Multiple Sclerosis Symptoms (IMSS) survey is now officially live! Why is…

1 2 3 4 5 28